Enterprise Therapeutics nabs Novartis VC exec as new CMO
Britain-based biotech Enterprise Therapeutics has hired Novartis Venture Fund managing director David Morris, M.D., as its next chief medical officer.
Britain-based biotech Enterprise Therapeutics has hired Novartis Venture Fund managing director David Morris, M.D., as its next chief medical officer.
In a quiet Securities and Exchange Commission (SEC) filing and with no press release, Wave Life Sciences announced it’s to cut its staff by nearly a quarter after a crushing few months.
The FDA approved the first artificial intelligence-powered software designed to assist and guide medical professionals without any specialized training through the steps of a cardiac ultrasound exam—one of the most common tools used to diagnose heart disease.
Long-troubled Valeritas, manufacturers of a wearable, disposable insulin pump, has filed for Chapter 11 bankruptcy as part of a plan to hand off its business to the specialty drugmaker Zealand Pharma, through a court-supervised sale.
List of Mutations That Causes Cancer – A Catalog of ‘Mutational Signatures’
New Study on Autism by NBRC scientists
Lab-Grown Muscle Cell Transplantation In Humans For The First Time
New Technologies in Brain Research – Recent Trends In Brain Research
Decoding the Mysteries of Human Brain
A new study reveals that we humans, including Africans who had been thought to have no genetic link to our extinct human relative, are likely to have a bit of Neanderthal in our DNA. Neanderthals are an extinct species or subspecies of archaic humans who lived about until 40,000 years ago in Eurasia.
One of the biggest threats to global health according to the World Health Organization is the threat of antibiotic resistance. There is an urgent need for us to change the way we use and prescribe antibiotics. Patients’ recovery can be improved by sensing and treating bacterial infections earlier and it would also limit the antibiotic-resistant microbes from spreading.